Transplantation after CD45-ADC corrects Rag1 immunodeficiency in congenic and haploidentical settings - 04/01/24
, Luigi D. Notarangelo, MD a, ⁎∗ Abstract |
Background |
Mutations in the recombinase-activating genes 1 and 2 (RAG1, RAG2) cause a spectrum of phenotypes, ranging from severe combined immune deficiency to combined immune deficiency with immune dysregulation (CID-ID). Hematopoietic cell transplantation is a curative option. Use of conditioning facilitates robust and durable stem cell engraftment and immune reconstitution but may cause toxicity. Transplantation from haploidentical donors is associated with poor outcome in patients with CID-ID.
Objectives |
We sought to evaluate multilineage engraftment and immune reconstitution after conditioning with CD45-antibody drug conjugate (CD45-ADC) as a single agent in hypomorphic mice with Rag1 mutation treated with congenic and haploidentical hematopoietic cell transplantation.
Methods |
Rag1-F971L mice, a model of CID-ID, were conditioned with various doses of CD45-ADC, total body irradiation, or isotype-ADC, and then given transplants of total bone marrow cells from congenic or haploidentical donors. Flow cytometry was used to assess chimerism and immune reconstitution. Histology was used to document reconstitution of thymic architecture.
Results |
Conditioning with CD45-ADC as a single agent allowed robust engraftment and immune reconstitution, with restoration of thymus, bone marrow, and peripheral compartments. The optimal doses of CD45-ADC were 1.5 mg/kg and 5 mg/kg for congenic and haploidentical transplantation, respectively. No graft-versus-host disease was observed.
Conclusions |
Conditioning with CD45-ADC alone allows full donor chimerism and immune reconstitution in Rag1 hypomorphic mice even following haploidentical transplantation, opening the way for the implementation of similar approaches in humans.
Le texte complet de cet article est disponible en PDF.Key words : CD45-ADC, RAG, immunodeficiency, immune dysregulation, hematopoietic cell transplantation, conditioning regimen, engraftment, immune reconstitution
Abbreviations used : ADC, BM, CD45-SAP, DN, DP, HCT, HSC, IR, Iso-ADC, MZ, PB, RAG, SCID, SP, TBI, WBC, WT
Plan
Vol 153 - N° 1
P. 341 - janvier 2024 Retour au numéro
Article précédent
- Racial and ethnic disparities in early mortality among patients with inborn errors of immunity
- Mei-Sing Ong, Nicholas L. Rider, Sarah Stein, Paul J. Maglione, Alison Galbraith, Daniel V. DiGiacomo, Jocelyn R. Farmer
- Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes
- Laura Polivka, Marine Madrange, Cristina Bulai-Livideanu, Stéphane Barete, Thomas Ballul, Antoine Neuraz, Celine Greco, Julie Agopian, Fabienne Brenet, Patrice Dubreuil, Charles Burdet, Richard Lemal, Olivier Tournilhac, Louis Terriou, David Launay, Laurence Bouillet, Clément Gourguechon, Ghandi Damaj, Laurent Frenzel, Cécile Meni, Hassiba Bouktit, Anne Florence Collange, Caroline Gaudy-Marqueste, Marie Gousseff, Edwige Le Mouel, Mohamed Hamidou, Antoine Neel, Dana Ranta, Roland Jaussaud, Philippe Guilpain, Danielle Canioni, Thierry Jo Molina, Julie Bruneau, Ludovic Lhermitte, Nicolas Garcelon, Rose-Marie Javier, Fabien Pelletier, Florence Castelain, Frederique Retornaz, Quentin Cabrera, Patricia Zunic, Marie Pierre Gourin, Ewa Wierzbicka-Hainaut, Jean François Viallard, Christian Lavigne, Cyrille Hoarau, Isabelle Durieu, Maël Heiblig, Sophie Dimicoli-Salazar, Jose Miguel Torregrosa-Diaz, Angèle Soria, Michel Arock, Olivier Lortholary, Christine Bodemer, Olivier Hermine, Julien Rossignol, CEREMAST network
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?